Product Pathways
BCP0027 BEZ235
Orally active PI3K tyrosine kinase inhibitor
BCP0107 Rapamycin
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor.
BCP0125 Temsirolimus
Temsirolimus (also known as CCI-779) is a recently developed mTOR inhibitor.
BCP0049 Deforolimus
Deforolimus (Ridaforolimus, AP23573, MK-8669) is a selective mTOR inhibitor.
BCP0056 Everolimus(RAD001)
Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.
BCP0195 PI103
A selective class I PI3K inhibitor.
BCP0203 KU0063794(KU63794)
Selective inhibitor of mammalian target of rapamycin (mTOR) (IC50 ~10 nM for mTORC1 and mTORC2 respectively).
BCP0283 PKI587
PKI-587 is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM, respectively.
BCP0485 AZD8055
Potent and selective mTOR inhibitor, with IC50 values to be 0.8 nM.
BCP000567 GSK2126458
A Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
第一页 1 2 3 4 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.